Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
暂无分享,去创建一个
Yong Cheng | J. Ji | Lei Yang | Ning Wang | Xi Zhang | Shuo Liu | Huichao Li | Qingyu Li
[1] Dennis Andersson,et al. Ensuring trust in COVID-19 data , 2021, Medicine.
[2] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[3] Xi Lin,et al. The diagnostic performance of automated versus handheld breast ultrasound and mammography in symptomatic outpatient women: a multicenter, cross-sectional study in China , 2020, European Radiology.
[4] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[5] Rachel Shikhman,et al. Breast Imaging Reporting and Data System , 2020, Definitions.
[6] A. Quante,et al. Is risk-stratified breast cancer screening economically efficient in Germany? , 2019, PloS one.
[7] D. Hughes,et al. Digital Breast Tomosynthesis Implementation: Considerations for Emerging Breast Cancer Screening Bundled Payment Models. , 2019, Journal of the American College of Radiology : JACR.
[8] Riccardo Manfredi,et al. Automated Breast Ultrasonography (ABUS) in the Screening and Diagnostic Setting: Indications and Practical Use. , 2018, Academic radiology.
[9] J. Seely,et al. Screening for breast cancer in 2018-what should we be doing today? , 2018, Current oncology.
[10] Ning Wang,et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. , 2018, The Lancet. Global health.
[11] J. Sitt,et al. Understanding breast cancer screening--past, present, and future. , 2018, Hong Kong medical journal = Xianggang yi xue za zhi.
[12] Melissa Matz,et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.
[13] J. Ji,et al. Cancer incidence in Beijing, 2014. , 2018, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[14] A. Vourtsis,et al. The performance of 3D ABUS versus HHUS in the visualisation and BI-RADS characterisation of breast lesions in a large cohort of 1,886 women , 2018, European Radiology.
[15] Sung Hun Kim,et al. Application of computer-aided diagnosis in breast ultrasound interpretation: improvements in diagnostic performance according to reader experience , 2017, Ultrasonography.
[16] T. Poulton,et al. Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities. , 2017, AJR. American journal of roentgenology.
[17] Nico Karssemeijer,et al. Volumetric breast density affects performance of digital screening mammography , 2016, Breast Cancer Research and Treatment.
[18] F. Song,et al. Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women , 2016, Scientific Reports.
[19] Anand K. Narayan,et al. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study , 2016, Breast Cancer Research and Treatment.
[20] T. Endo,et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial , 2016, The Lancet.
[21] K. Straif,et al. Breast-cancer screening--viewpoint of the IARC Working Group. , 2015, The New England journal of medicine.
[22] Bin Zhang,et al. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women , 2015, British Journal of Cancer.
[23] N. Boyd,et al. Mammographic features associated with interval breast cancers in screening programs , 2014, Breast Cancer Research.
[24] Yaogang Wang,et al. Distribution of mammographic density and its influential factors among Chinese women. , 2014, International journal of epidemiology.
[25] Wanqing Chen,et al. Breast cancer in China. , 2014, The Lancet. Oncology.
[26] Yi Wang,et al. Comparative study of automated breast 3-D ultrasound and handheld B-mode ultrasound for differentiation of benign and malignant breast masses. , 2013, Ultrasound in medicine & biology.
[27] C. de Wolf,et al. Mammographic Screening Programmes in Europe: Organization, Coverage and Participation , 2012, Journal of medical screening.
[28] Y. Qiao,et al. A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china , 2011, BMC Cancer.
[29] A. Derossis,et al. Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.
[30] S. Haneuse,et al. Performance of first mammography examination in women younger than 40 years. , 2010, Journal of the National Cancer Institute.
[31] J. Lakshmanan,et al. Randomised controlled trial , 2006 .
[32] MD EttaD.Pisano,et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. , 2008, Radiology.
[33] D. Miglioretti,et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.
[34] Emily White,et al. Factors contributing to mammography failure in women aged 40-49 years. , 2004, Journal of the National Cancer Institute.
[35] T. M. Kolb,et al. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. , 2002, Radiology.
[36] W. Willett,et al. Harvard Report on Cancer Prevention Volume 4: Harvard Cancer Risk Index , 2004, Cancer Causes & Control.